Browse by Audience
Skip to content
Papers of the Week
Patient-reported outcomes of migraine treatment with erenumab: results from a national patient survey.
Abstract
Despite development of new therapies, migraine remains an undertreated illness. It is important to understand patients' preferences and perceptions of using a certain therapy. We present data from a nationwide Lithuanian survey of patients' experience using erenumab for the treatment of high frequency episodic and chronic migraine.